NeuroAudit
Neuromodulation Protocols for Personalized Brain Disease Treatment
StartupNeuroAudit is a Gan Sorek-based startup in the Health Tech & Life Sciences sector, established in 2016. Neuromodulation Protocols for Personalized Brain Disease Treatment. The company has raised a total of $200K across 1 funding round, currently at the Seed stage. NeuroAudit was founded by Dan Anzyo. The company has 1-10 employees. Core technologies: Simulation & Imaging, Ultrasound.
With $200K in total funding, NeuroAudit is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial.
- StageSeed
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQGan Sorek
- DistrictCenter District
- Last Round$200K
Dan AnzyoCEO
What does NeuroAudit do?
NeuroAudit, the developer of neuro stimulus neurotechnology, is currently working on a cognitive boost patch for the treatment of brain disorders such as Alzheimers disease and cognitive disorders. Based on blood conduction directly to the brain using a unique algorithm, the device transmits a noninvasive, pure signal through a patch attached to the skin. The device is not mounted in or near the ears of the patient. NeuroAudit is focused on addressing the complexities of neurological disorders by continuously monitoring the state of the brain while analyzing the measured data and controlling brain stimulation in real time in order to better understand the impact on the brain. The companys noninvasive stimulation has showed improvements in certain cognitive operations and was able to send a pure tone to a completely deaf individual via the blood using an ultrasonic algorithm. Additional use cases include creating a new brain-hearing sense to expand the range of the human brains hearing up to 100 KHz and using specific modulations to expand a individuals level of cognition.
How much funding has NeuroAudit raised?
NeuroAudit has raised $200K in total funding across 1 rounds. The company is currently at the Seed stage.
Who founded NeuroAudit?
NeuroAudit was founded in 2016 by Dan Anzyo (CEO).
What sector is NeuroAudit in?
NeuroAudit operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Simulation & Imaging, Ultrasound. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is NeuroAudit located?
NeuroAudit is based in Gan Soreq, Israel, Center District.